<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928772</url>
  </required_header>
  <id_info>
    <org_study_id>14694</org_study_id>
    <nct_id>NCT00928772</nct_id>
  </id_info>
  <brief_title>Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety</brief_title>
  <official_title>The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cranial electro stimulation (CES) provides safe, adequate, side-effect free sedation without
      excessive drowsiness in preoperative settings.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      CES Alpha-Stim is a non-invasive device which has been in place and has been approved for
      patients to reduce anxiety by the FDA. This study involves the use of CES Alpha-Stim device
      applied to the patient 30 minutes before and through-out cataract surgery procedure and then
      to measure the level of anxiety and discomfort by using a visual analog scale (VAS). We
      propose that by applying the device the patients will be able to have markedly less level of
      anxiety and discomfort before and during the surgery and will ultimately avoid the
      traditional use of sedative or analgesic drugs being used for these kinds of surgery.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Lack of efficacy
  </why_stopped>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety During Cataract Surgery Under Topical Anesthesia</measure>
    <time_frame>during the cataract surgery up to30 minutes</time_frame>
    <description>Anxiety was accessed via VAS from 0 to 10 with 10 being the most anxious.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Eye Discomfort Perception During Cataract Surgery Under Topical Anesthesia</measure>
    <time_frame>during cataract surgery up to 30 minutes</time_frame>
    <description>VAS from 0 to 10 with 10 being maximal discomfort percieved</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia</measure>
    <time_frame>during cataract surgery up to 30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate During Cataract Surgery Under Topical Anesthesia</measure>
    <time_frame>during cataract surgery up to 30 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">115</enrollment>
  <condition>Anxiety</condition>
  <arm_group>
    <arm_group_label>Alpha-Stim intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One hour Alpha-Stim intervention with sham midazolam</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Alpha-Stim with midazolam</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham Alpha-Stim intervention with real midazolam administration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No Alpha-Stim and only topical anesthetics</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM</intervention_name>
    <description>APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
    <arm_group_label>Alpha-Stim intervention</arm_group_label>
    <other_name>AlphaStim</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY</intervention_name>
    <description>CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
    <arm_group_label>Sham Alpha-Stim with midazolam</arm_group_label>
    <other_name>VERSED</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED</intervention_name>
    <description>NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of both genders between 50 and 90 years old scheduled for an outpatient
             &quot;first eye&quot; cataract phacoemulsification with topical anesthesia.

          -  ASA classification I II and III

        Exclusion Criteria:

          -  ASA classification IV (patients with a chronic or severe disease).

          -  Hypersensitivity to midazolam or benzodiazepines

          -  acute narrow-angle glaucoma

          -  untreated open-angle glaucoma

          -  Patients with any sort of psychiatric or neurological disorder

          -  Patients on anti-anxiety medication

          -  Patients who have demand-type pacemakers installed before 1999* *Note: These are the
             exclusions listed for liability purposes by Alpha-Stim. There are no FDA exclusions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grigory Chernyak</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oklahoma City VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oklahoma City VA Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2009</study_first_submitted>
  <study_first_submitted_qc>June 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2009</study_first_posted>
  <results_first_submitted>April 19, 2017</results_first_submitted>
  <results_first_submitted_qc>April 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">April 20, 2017</results_first_posted>
  <last_update_submitted>April 19, 2017</last_update_submitted>
  <last_update_submitted_qc>April 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cranial Electro Stimulation</keyword>
  <keyword>First Eye Cataract Surgery</keyword>
  <keyword>Preoperative sedation</keyword>
  <keyword>Perioperative sedation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Alpha-Stim Intervention</title>
          <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
        </group>
        <group group_id="P2">
          <title>Sham Alpha-Stim With Midazolam</title>
          <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
        </group>
        <group group_id="P3">
          <title>Placebo</title>
          <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="38"/>
                <participants group_id="P3" count="38"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Alpha-Stim Intervention</title>
          <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
        </group>
        <group group_id="B2">
          <title>Sham Alpha-Stim With Midazolam</title>
          <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
        </group>
        <group group_id="B3">
          <title>Placebo</title>
          <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="39"/>
            <count group_id="B2" value="38"/>
            <count group_id="B3" value="38"/>
            <count group_id="B4" value="115"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>50-90 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="38"/>
                    <measurement group_id="B4" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Anxiety During Cataract Surgery Under Topical Anesthesia</title>
        <description>Anxiety was accessed via VAS from 0 to 10 with 10 being the most anxious.</description>
        <time_frame>during the cataract surgery up to30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alpha-Stim Intervention</title>
            <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
          </group>
          <group group_id="O2">
            <title>Sham Alpha-Stim With Midazolam</title>
            <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
          </group>
        </group_list>
        <measure>
          <title>Anxiety During Cataract Surgery Under Topical Anesthesia</title>
          <description>Anxiety was accessed via VAS from 0 to 10 with 10 being the most anxious.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.19" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O2" value="2.96" lower_limit="1" upper_limit="9"/>
                    <measurement group_id="O3" value="4.10" lower_limit="1" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Eye Discomfort Perception During Cataract Surgery Under Topical Anesthesia</title>
        <description>VAS from 0 to 10 with 10 being maximal discomfort percieved</description>
        <time_frame>during cataract surgery up to 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alpha-Stim Intervention</title>
            <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
          </group>
          <group group_id="O2">
            <title>Sham Alpha-Stim With Midazolam</title>
            <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
          </group>
        </group_list>
        <measure>
          <title>Eye Discomfort Perception During Cataract Surgery Under Topical Anesthesia</title>
          <description>VAS from 0 to 10 with 10 being maximal discomfort percieved</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.58" lower_limit="1" upper_limit="7"/>
                    <measurement group_id="O2" value="2.66" lower_limit="1" upper_limit="8"/>
                    <measurement group_id="O3" value="2.79" lower_limit="1" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia</title>
        <time_frame>during cataract surgery up to 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alpha-Stim Intervention</title>
            <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
          </group>
          <group group_id="O2">
            <title>Sham Alpha-Stim With Midazolam</title>
            <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Arterial Pressure During the Cataract Surgery Under Topical Anesthesia</title>
          <units>mmHg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="99.5" lower_limit="74.6" upper_limit="135.3"/>
                    <measurement group_id="O2" value="99.8" lower_limit="66.7" upper_limit="126.3"/>
                    <measurement group_id="O3" value="104.5" lower_limit="79" upper_limit="124.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Heart Rate During Cataract Surgery Under Topical Anesthesia</title>
        <time_frame>during cataract surgery up to 30 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alpha-Stim Intervention</title>
            <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
          </group>
          <group group_id="O2">
            <title>Sham Alpha-Stim With Midazolam</title>
            <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
          </group>
        </group_list>
        <measure>
          <title>Heart Rate During Cataract Surgery Under Topical Anesthesia</title>
          <units>Beats per minute</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="39"/>
                <count group_id="O2" value="38"/>
                <count group_id="O3" value="38"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.6" lower_limit="53" upper_limit="88"/>
                    <measurement group_id="O2" value="65.4" lower_limit="48" upper_limit="80"/>
                    <measurement group_id="O3" value="67.9" lower_limit="47" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Alpha-Stim Intervention</title>
          <description>One hour Alpha-Stim intervention with sham midazolam
CRANIAL ELECTROTHERAPY (Alpha Stim) + SHAM MIDAZOLAM: APPLYING OF ELECTRODES ON THE EAR LOBES AND TEMPLES WHICH ARE SENDING AN ACTIVE MICROCURRENT THROUGH THE MIDBRAIN PRODUCING SEDATION WITHOUT PHARMACOLOGICAL AGENTS AND GIVING NORMAL SALINE AS A SHAM DRUG SEDATION</description>
        </group>
        <group group_id="E2">
          <title>Sham Alpha-Stim With Midazolam</title>
          <description>Sham Alpha-Stim intervention with real midazolam administration
MIDAZOLAM + SHAM ELECTRODES SIMULATING CRANIAL ELECTROTHERAPY: CONVENTIONAL METHOD OF PERIOPERATIVE SEDATION</description>
        </group>
        <group group_id="E3">
          <title>Placebo</title>
          <description>No Alpha-Stim and only topical anesthetics
NO SEDATION WITH SHAM CRANIAL ELECTROSTIMULATION AND PLACEBO VERSED: NO ACTIVE SEDATION, ONLY SHAM ELECTRODES AND NORMAL SALINE SIMULATING MIDAZOLAM.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="38"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Grigory Chernyak, MD</name_or_title>
      <organization>VAMC</organization>
      <phone>405-326-1885</phone>
      <email>grigory.chernyak@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

